UK markets open in 4 hours 32 minutes
  • NIKKEI 225

    26,298.35
    +190.70 (+0.73%)
     
  • HANG SENG

    21,364.50
    -222.16 (-1.03%)
     
  • CRUDE OIL

    97.64
    -0.89 (-0.90%)
     
  • GOLD FUTURES

    1,738.00
    +1.50 (+0.09%)
     
  • DOW

    31,037.68
    +69.86 (+0.23%)
     
  • BTC-GBP

    17,122.82
    +365.48 (+2.18%)
     
  • CMC Crypto 200

    444.76
    +9.23 (+2.12%)
     
  • ^IXIC

    11,361.85
    +39.61 (+0.35%)
     
  • ^FTAS

    3,910.80
    +46.89 (+1.21%)
     

Human Longevity plans to go public in $1 billion blank-check deal

  • Oops!
    Something went wrong.
    Please try again later.
·1-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

(Reuters) - Genome sequencing company Human Longevity Inc plans to go public through a merger with Freedom Acquisition I Corp that values the combined company at about $1 billion, the two companies said on Monday.

The announcement followed the signing of a non-binding letter of intent, although the companies said that there is no assurance of a definitive agreement or completion of a deal.

Freedom Acquisition I Corp is a special purpose acquisition company led by former Credit Suisse chief executive Tidjane Thiam, and was listed early last year.

A blank-check firm, or a special purpose acquisition company (SPAC), is a listed shell entity that uses the money raised in its IPO to merge with a private company, taking it public in the process.

(Reporting by Leroy Leo in Bengaluru; editing by Richard Pullin)

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting